Abstract Body

Background: HIV-1 infection is controlled, but not cured, by combination antiretroviral therapy (cART). Mechanisms of persistence are not well understood although recently a number of groups identified expanded clones of HIV infected cells with proviruses integrated in genes involved in growth promotion. Antineoplastic chemotherapy (CTX) includes agents that target proliferating cells and may therefore have an effect on HIV infected cells. Previously, no long term effects of CTX on levels of total cell associated HIV DNA were detected (Cillo et al., 2013); HIV infects diverse CD4 subsets and differential effects of CTX on structure of HIV populations may occur. We investigated the effects of chemotherapeutic agents on HIV populations in infected individuals undergoing CTX.

Methods: HIV-1 infected patients (N=10) undergoing CTX were identified, and samples were obtained from patients with B cell lymphoma treated with EPOCH-R in the absence of cART (N=6), and from patients with Kaposi’s Sarcoma undergoing cART treated with either Paclitaxel or Doxorubicin (N=4). Samples were obtained prior to CTX, during CTX (cycles 1-6) and following CTX completion. HIV single genome sequences (SGS) were obtained, aligned (CLUSTALW), and subjected to phylogenetic and compartmentalization analyses (Simmonds AI, Slatkin-Maddison, and Hudson Population Subdivision tests). Hypermutants and drug resistance mutations were identified using Los Alamos and Stanford Drug Resistance Databases, respectively.

Results: In patients on a regimen of EPOCH-R for B cell lymphoma, in the absence of cART, populations of identical HIV sequences appeared in plasma during chemotherapy with evidence of clonal populations in 2/6 and population subdivision in 1/6 patients. In patients undergoing cART and receiving single agent CTX, no clonal sequences were detected in plasma; clonal populations were detected prior to therapy in cell associated HIV DNA in 4/4 patients on single agent CTX which persisted with no evidence of compartmentalization or population subdivision. No significant change in hypermutant frequency was detected prior to and following therapy in either study.

Conclusions: EPOCH-R during untreated HIV infection resulted in HIV population changes in some patients, suggesting effects of chemotherapy in HIV infected cells. In contrast, single agent chemotherapy had minimal detectable effect on HIV populations.